BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Jin Y, Wang B, Wang Y, Zuo S, Zhang J. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome. Biochem Biophys Res Commun 2021;561:7-13. [PMID: 33992835 DOI: 10.1016/j.bbrc.2021.04.098] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Deng J, Huang M, Wu H. Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating nuclear factor - like 2 and Sirtuin 2 signaling pathways. Bioengineered 2021;12:7975-84. [PMID: 34565300 DOI: 10.1080/21655979.2021.1985299] [Reference Citation Analysis]
2 Jin X, Yu W, Ye P. MiR-125b enhances doxorubicin-induced cardiotoxicity by suppressing the nucleus-cytoplasmic translocation of YAP via targeting STARD13. Environ Toxicol 2021. [PMID: 34921586 DOI: 10.1002/tox.23438] [Reference Citation Analysis]
3 Wang Z, Wen P, Hu B, Cao S, Shi X, Guo W, Zhang S. Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma. Cancer Cell Int 2021;21:586. [PMID: 34717619 DOI: 10.1186/s12935-021-02298-9] [Reference Citation Analysis]
4 Yang HB, Lu ZY, Yuan W, Li WD, Mao S. Selenium Attenuates Doxorubicin-Induced Cardiotoxicity Through Nrf2-NLRP3 Pathway. Biol Trace Elem Res 2021. [PMID: 34462843 DOI: 10.1007/s12011-021-02891-z] [Reference Citation Analysis]
5 Li M, Zhou L, Sun X, Yang Y, Zhang C, Wang T, Fu F. Dopamine, a co-regulatory component, bridges the central nervous system and the immune system. Biomed Pharmacother 2022;145:112458. [PMID: 34847478 DOI: 10.1016/j.biopha.2021.112458] [Reference Citation Analysis]